Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Selling and marketing

General and administrative

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Progenity

Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Progenity spent 2021 reinventing itself, dumping its testing laboratory, hiring a new CEO, and refocusing on its patent portfolio. PROG stock hopes its patent portfolio can result in new tests and treatments for disease, but mining it will take time and money.

Progenity Stock's Hype Cycle Is Over, It Needs Results

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that two presentations with patient data on indicators of efficacy in the treatment of gastrointestinal disorders have been accepted by the 17th Congress of the European Crohn's and Colitis Organisation (ECCO), February 16-19, 2022, the world's largest forum for IBD specialists. ECCO's mission is to improve the care of patients with IBD through international guidelines, education, research, and collaboration.

Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO'22

American Virtual Cloud Technologies

Tonix Pharmaceuticals Hld

Are these penny stocks on your January watchlist? The post Are These Penny Stocks on Your January 2022 List?

Are These Penny Stocks on Your January 2022 List?

There's a mismatch as Progenity's patent portfolio keeps growing, yet PROG stock has declined. A turnaround could be in store very soon.

PROG Stock Is a Buy As Progenity Becomes a Leaner Company

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that the company will participate in a pre-recorded presentation at the H.C. Wainwright BIOCONNECT Virtual Conference. The presentation will be available on the conference website beginning at 7 a.m. Eastern / 4 a.m. Pacific on January 10, 2022.

Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference

Inspira Technologies Oxy BHN Ltd

Wish

Most active penny stocks to watch right now. The post Most Active Penny Stocks To Watch Before 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Most Active Penny Stocks To Watch Before 2022

PROG stock collapsed over the past 18 months, leading to hopes of a quick recovery. But it won't happen given the firm's fundamental problems.

Progenity is Still a Sell as Company Lacks Catalysts

Progenity is transitioning away from molecular testing operations to focus on the development of biotherapeutics. In this respect, the third quarter's financials were pivotal to the transformation strategy as it translated into a reduction in operational expenses as planned.

Progenity: The Transition Is Well Under Way

Transaction Adds Cash to Balance Sheet and Further Reduces Operating Expenses Transaction Adds Cash to Balance Sheet and Further Reduces Operating Expenses

Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab

Can-Fite BioPharma Ltd.

Digital Ally Inc

Mereo Biopharma Group Plc - ADR

OPKO Health

5 penny stocks to buy for under $5 right now. Are they worth the risk?

5 Penny Stocks To Buy For Under $5 This Week

Camber Energy

Farmmi

Are these penny stocks on your list for the New Year? The post Best Penny Stocks to Buy Now?

Best Penny Stocks to Buy Now? Check These 3 Out in 2022

Powerbridge Technologies Co Ltd

Transocean

Are these penny stocks on your watchlist as December ends? The post Penny Stocks to Watch During the Omicron Surge And the Fed Meeting appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks to Watch During the Omicron Surge And the Fed Meeting

Progenity went public in June 2020. Eighteen months later, PROG stock has lost 83% of its value.

Progenity Is Unlikely to Live Up to Its IPO Hype

Arbutus Biopharma

Alzamend Neuro

CTI BioPharma

Katapult Holdings

5 penny stocks analysts say are a buy right now with hefty price targets. The post Penny Stocks To Buy According To 5 Analysts With 55%-246% Targets appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks To Buy According To 5 Analysts With 55%-246% Targets

Biotechnology sector traders should put PROG stock on their radars as it has demonstrated the ability to make 2x, 3x moves and more. The post Range of Therapeutic Products Puts Progenity Above Peers appeared first on InvestorPlace.

Range of Therapeutic Products Puts Progenity Above Peers

Biotech play PROG stock will likely continue to move wildly, until it makes breakthroughs with its promising pipeline. The post The Long-Term Story Still Holds True for Volatile Progenity Stock appeared first on InvestorPlace.

The Long-Term Story Still Holds True for Volatile Progenity Stock

Alset EHome International

Ardelyx

Are any of these penny stocks on your watchlist right now? The post 3 Penny Stocks With Bullish Investor Interest Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks With Bullish Investor Interest Right Now

The money has already been made on PROG stock and there is little incentive to invest in this one beyond the potential of a short squeeze. The post Progenity Stock Needs to Fall Further to Become a Viable Investment appeared first on InvestorPlace.

Progenity Stock Needs to Fall Further to Become a Viable Investment

Progenity's products are well-positioned to save a great deal of time and money, while the valuation of PROG stock is reasonable. The post Progenity Stock Looks Poised to Become a Big Winner appeared first on InvestorPlace.

Progenity Stock Looks Poised to Become a Big Winner

The stock price of Progenity Inc (NASDAQ: PROG) increased by 19.49% today. This is why it happened.

Progenity Stock (PROG): Why The Price Jumped Today

SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a new patent related to its single-molecule detection platform under development.

Progenity Announces New Patent for Single-Molecule Detection Technology

The biotech has given investors a bumpy ride this month.

Why Shares of Progenity Are Down More Than 11% on Wednesday

Unique delivery of GI-disease treatments -- along with multiple liquidity infusions -- should help to ease the concerns of PROG stock holders. The post Capital Raises Add Confidence to Fast-Moving Biotech Progenity appeared first on InvestorPlace.

Capital Raises Add Confidence to Fast-Moving Biotech Progenity

Clover Health Investments

Express

Meta Materials

Phunware Inc

Lordstown Motors

Before you close the books on 2021, if you hold a position in any of these seven penny stocks to sell, make sure to make your exit. Camber Energy (NYSEAMERICAN:CEI) Clover Health (NASDAQ:CLOV) Express (NYSE:EXPR) Meta Materials (NASDAQ:MMAT) Phunware (NASDAQ:PHUN) Progenity (NASDAQ:PROG) Lordstown Motors (NASDAQ:RIDE) The post 7 Penny Stocks to Sell Before Year End appeared first on InvestorPlace.

7 Penny Stocks to Sell Before Year End

Shares of penny stock PROG are on the move and here's what's going on. The post Hot Penny Stocks Today: Why Is PROG Stock Moving?

News for Progenity Stock (PROG)